IS7686A - Ný bólgueyðandi efni sem ekki eru sterar, efnablöndur og aðferðir til að nota þau - Google Patents

Ný bólgueyðandi efni sem ekki eru sterar, efnablöndur og aðferðir til að nota þau

Info

Publication number: IS7686A
Authority: IS; Iceland
Prior art keywords: preparations; methods; steroidal anti; new non; inflammatory substances
Prior art date: 2002-07-08

Application number

IS7686A

Other languages

English (en)

Inventor

Mercep Mladen

Mesic Milan

Tomaskovic Linda

Markovic Stribor

Original Assignee

Pliva - Istrazivacki Institut D.O.O.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-08

Filing date

2005-02-04

Publication date

2005-02-04

2005-02-04 Application filed by Pliva - Istrazivacki Institut D.O.O. filed Critical Pliva - Istrazivacki Institut D.O.O.

2005-02-04 Publication of IS7686A publication Critical patent/IS7686A/is

Links

239000002260 anti-inflammatory agent Substances 0.000 title 1
238000000034 method Methods 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
230000003637 steroidlike Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pulmonology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Dermatology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Transplantation (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Communicable Diseases (AREA)

IS7686A 2002-07-08 2005-02-04 Ný bólgueyðandi efni sem ekki eru sterar, efnablöndur og aðferðir til að nota þau IS7686A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US39467102P	2002-07-08	2002-07-08
PCT/HR2003/000035 WO2004005309A2 (en)	2002-07-08	2003-07-07	Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use

Publications (1)

Publication Number	Publication Date
IS7686A true IS7686A (is)	2005-02-04

Family

ID=30115753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7686A IS7686A (is)	2002-07-08	2005-02-04	Ný bólgueyðandi efni sem ekki eru sterar, efnablöndur og aðferðir til að nota þau

Country Status (15)

Country	Link
US (1)	US7109176B2 (is)
EP (1)	EP1521763A2 (is)
JP (2)	JP2005536488A (is)
CN (1)	CN100417659C (is)
AR (1)	AR040951A1 (is)
AU (1)	AU2003255849A1 (is)
BR (1)	BR0312584A (is)
CA (1)	CA2489398A1 (is)
IS (1)	IS7686A (is)
NO (1)	NO20050571L (is)
NZ (1)	NZ537716A (is)
PL (1)	PL374646A1 (is)
RS (1)	RS20050007A (is)
RU (1)	RU2342398C2 (is)
WO (1)	WO2004005309A2 (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1483579A4 (en) *	2002-02-15	2006-07-12	Merckle Gmbh	CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS FOR THE PREPARATION AND USE OF CONJUGATES, FORMULATION AND PHARMACEUTICAL APPLICATIONS OBTAINED FROM SUCH CONJUGATES
TW200420573A (en) *	2002-09-26	2004-10-16	Rib X Pharmaceuticals Inc	Bifunctional heterocyclic compounds and methods of making and using same
CN1780846A (zh) *	2003-03-05	2006-05-31	Rib－X医药品有限公司	双官能杂环化合物及其制备和使用方法
HRP20030324A2 (en) *	2003-04-24	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	Compounds of antiinflammatory effect
WO2005042554A1 (en) *	2003-10-30	2005-05-12	Rib-X Pharmaceuticals, Inc.	Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US20070270357A1 (en) *	2003-11-18	2007-11-22	Farmer Jay J	Bifunctional Macrolide Heterocyclic Compounds and Methods of Making and Using the Same
US8202843B2 (en)	2004-02-27	2012-06-19	Rib-X Pharmaceuticals, Inc.	Macrocyclic compounds and methods of making and using the same
US20060183696A1 (en) *	2004-08-12	2006-08-17	Pliva-Istrazivacki Institut D.O.O.	Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
EP1778292A2 (en) *	2004-08-12	2007-05-02	GlaxoSmithKline istrazivacki centar Zagreb d.o.o.	Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract
ES2337915T3 (es)	2004-10-27	2010-04-30	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Conjugados con adtividad antiinflamatoria.
US20080096830A1 (en) *	2005-01-13	2008-04-24	Mladen Mercep	Anti-Inflammatory Macrolide Conjugates
WO2007012464A1 (en) *	2005-07-26	2007-02-01	Merckle Gmbh	Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
WO2009006403A2 (en) *	2007-06-29	2009-01-08	Georgia Tech Research Corporation	Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof
US8871728B2 (en)	2007-06-29	2014-10-28	Georgia Tech Research Corporation	Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
US9145436B2 (en)	2010-10-10	2015-09-29	Michael W. Burnet	Anti-inflammatory macrolides
JP5926484B2 (ja)	2010-11-18	2016-05-25	株式会社セルシード	グリコサミノグリカンの新規な分析方法
US10278925B2 (en)	2012-01-04	2019-05-07	Wellesley Pharmaceuticals, Llc	Delayed-release formulations, methods of making and use thereof
MX2014008284A (es) *	2012-01-04	2015-03-03	Wellesley Pharmaceutical Llc	Formulacion de liberacion retardada para reducir la frecuencia de orinar y metodos de uso de esta.
JP7759693B2 (ja)	2018-09-14	2025-10-24	ジャンインユスンファーマシューティカルカンパニー，リミテッド	モンテルカストおよびペプチドの新規接合体
WO2023248010A2 (en) *	2022-06-23	2023-12-28	Synovo Gmbh	Targeted modulators of jak3 for treatment of inflammatory and autoimmune diseases

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB327084A (en) *	1928-10-19	1930-03-27	Ver Stahlwerke Ag	Improved method of and apparatus for introducing material to be rolled into rolling mills
US4474768A (en)	1982-07-19	1984-10-02	Pfizer Inc.	N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
DE3860503D1 (de) *	1987-09-03	1990-10-04	Pliva Pharm & Chem Works	10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
LU87036A1 (fr)	1987-11-04	1989-06-14	Oreal	Esters cycloaliphatiques insatures d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
US5466681A (en) *	1990-02-23	1995-11-14	Microcarb, Inc.	Receptor conjugates for targeting penicillin antibiotics to bacteria
US5965566A (en)	1993-10-20	1999-10-12	Enzon, Inc.	High molecular weight polymer-based prodrugs
ES2183166T3 (es)	1996-04-26	2003-03-16	Massachusetts Inst Technology	Ensayo de cribado por triple hibrido.
HRP960497B1 (en) *	1996-10-28	2003-08-31	Pliva Pharm & Chem Works	9-n-ethenyl derivatives of 9(s)-erythromycylamine
GB2321455A (en) *	1997-01-24	1998-07-29	Norsk Hydro As	Lipophilic derivatives of biologically active compounds
HN1998000074A (es) *	1997-06-11	1999-01-08	Pfizer Prod Inc	Derivados de macrolidos c-4 sustituidos
GB2327084A (en)	1997-07-08	1999-01-13	Merck & Co Inc	9a-Aza-3-ketolide antibiotics
EP0895999A1 (en) *	1997-08-06	1999-02-10	Pfizer Products Inc.	C-4" substituted macrolide antibiotics
WO1999028308A1 (en)	1997-11-29	1999-06-10	Truett William L	Antibiotics and process for preparation
AU4549999A (en) *	1998-06-08	1999-12-30	Advanced Medicine, Inc.	Novel polyene macrolide compounds and uses
EP1085846A2 (en) *	1998-06-08	2001-03-28	Advanced Medicine, Inc.	Multibinding inhibitors of microsomal triglyceride transferase protein
US6043227A (en) *	1998-08-19	2000-03-28	Pfizer Inc.	C11 carbamates of macrolide antibacterials
IT1306205B1 (it) *	1999-01-15	2001-05-30	Zambon Spa	Macrolidi ad attivita' antiinfiammatoria.
EP1046394A3 (en)	1999-04-19	2001-10-10	ImaRx Pharmaceutical Corp.	Novel compositions useful for delivering compounds into a cell
GB9909229D0 (en)	1999-04-23	1999-06-16	Glaxo Group Ltd	Enantiomers of mercapto lactones and processes for their synthesis
US7402556B2 (en)	2000-08-24	2008-07-22	Medarex, Inc.	Prodrugs activated by plasmin and their use in cancer chemotherapy
HRP20010018A2 (en) *	2001-01-09	2002-12-31	Pliva D D	Novel anti-inflammatory compounds
EP1483579A4 (en)	2002-02-15	2006-07-12	Merckle Gmbh	CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS FOR THE PREPARATION AND USE OF CONJUGATES, FORMULATION AND PHARMACEUTICAL APPLICATIONS OBTAINED FROM SUCH CONJUGATES
US20040186063A1 (en) *	2002-02-15	2004-09-23	Hans-Jurgen Gutke	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
NZ535354A (en) *	2002-02-15	2008-01-31	Merckle Gmbh	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP1482957A4 (en)	2002-02-15	2006-07-19	Merckle Gmbh	ANTIBIOTIC CONJUGATES

2003
- 2003-07-07 US US10/615,010 patent/US7109176B2/en not_active Expired - Fee Related
- 2003-07-07 EP EP03762824A patent/EP1521763A2/en not_active Withdrawn
- 2003-07-07 JP JP2004519020A patent/JP2005536488A/ja active Pending
- 2003-07-07 WO PCT/HR2003/000035 patent/WO2004005309A2/en not_active Ceased
- 2003-07-07 AU AU2003255849A patent/AU2003255849A1/en not_active Abandoned
- 2003-07-07 BR BR0312584-0A patent/BR0312584A/pt not_active IP Right Cessation
- 2003-07-07 CN CNB038160927A patent/CN100417659C/zh not_active Expired - Fee Related
- 2003-07-07 PL PL03374646A patent/PL374646A1/xx not_active Application Discontinuation
- 2003-07-07 RS YUP-2005/0007A patent/RS20050007A/sr unknown
- 2003-07-07 RU RU2005103227/04A patent/RU2342398C2/ru not_active IP Right Cessation
- 2003-07-07 NZ NZ537716A patent/NZ537716A/en unknown
- 2003-07-07 CA CA002489398A patent/CA2489398A1/en not_active Abandoned
- 2003-07-10 AR ARP030102489A patent/AR040951A1/es unknown
2005
- 2005-02-02 NO NO20050571A patent/NO20050571L/no not_active Application Discontinuation
- 2005-02-04 IS IS7686A patent/IS7686A/is unknown
2010
- 2010-09-21 JP JP2010211027A patent/JP2011006474A/ja not_active Ceased

Also Published As

Publication number	Publication date
RS20050007A (sr)	2007-09-21
AU2003255849A1 (en)	2004-01-23
PL374646A1 (en)	2005-10-31
JP2005536488A (ja)	2005-12-02
CA2489398A1 (en)	2004-01-15
WO2004005309A2 (en)	2004-01-15
AR040951A1 (es)	2005-04-27
RU2005103227A (ru)	2005-07-20
HK1080865A1 (en)	2006-05-04
WO2004005309A3 (en)	2004-04-15
CN1665829A (zh)	2005-09-07
US20040097434A1 (en)	2004-05-20
NZ537716A (en)	2007-05-31
JP2011006474A (ja)	2011-01-13
EP1521763A2 (en)	2005-04-13
US7109176B2 (en)	2006-09-19
NO20050571L (no)	2005-03-31
CN100417659C (zh)	2008-09-10
BR0312584A (pt)	2005-04-12
RU2342398C2 (ru)	2008-12-27

Publication	Publication Date	Title
IS7686A (is)	2005-02-04	Ný bólgueyðandi efni sem ekki eru sterar, efnablöndur og aðferðir til að nota þau
IS7726A (is)	2005-03-04	Pyrazólólpyridín og aðferðir til þess að búa þau til og nota
DK1511734T3 (da)	2010-08-02	Forbindelser, præparater og fremgangsmåder
DK1549736T3 (da)	2009-07-20	Pentose-sukker-fermenterende zymomonas-stamme og anvendelser deraf
GB0215044D0 (en)	2002-08-07	Sampling kits, devices and uses thereof
IS7684A (is)	2005-02-03	Ný efnasambönd, blöndur og aðferðir til að meðhöndla bólgusjúkdóma og -ástand
FI20021905A0 (fi)	2002-10-25	Jännitteenkertoja
DK1682446T3 (da)	2012-09-24	Lithiummetalphosphater, fremgangsmåde til deres fremstilling og anvendelse som elektrodematerialer
NO20051397D0 (no)	2005-03-17	Enkeltfase samlingsapparat og fremgangsmate
IS8434A (is)	2006-04-27	Verndandi vírnet, verndandi formgerð búin til meðnetinu og notkunin á verndandi vírnetinu við að búa til verndandi formgerð
EP1585532A4 (en)	2008-09-24	TOPICAL INFECTION-INHIBITING FORMULATIONS
ITMI20020148A1 (it)	2003-07-29	Nuovi corticosteroidi
NO20051983D0 (no)	2005-04-22	3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav.
FI20020565A7 (fi)	2003-09-26	Kennorakenne, laite ja menetelmä
DE50313445D1 (de)	2011-03-10	Ikgerät, sowie verwendung dazu
IS7694A (is)	2005-02-11	Sterasamrunaefnasambönd, framleiðsla og notkun þeirra
ITMI20020549A0 (it)	2002-03-15	Modulatore criogenico per gascromatografia
ITMI20020872A0 (it)	2002-04-23	Derivati dell'iperforina loro uso e formulazioni che li contengono
ES1053583Y (es)	2004-02-16	Encofrado recuperable para forjados y similares.
EP1660088A4 (en)	2009-04-29	PYRIDOMORPHINANE, PYRIDAZINOMORPHINANE AND ITS USE
DK1313873T3 (da)	2008-07-14	Modificeret gær og anvendelse heraf, navnlig til produktion af steroidderivater
NL1022083A1 (nl)	2003-03-21	Scherminrichting, profiel en kas waarin zulks is toegepast.
DK1490510T3 (da)	2008-09-15	Hidtil ukendte primere til at identificere aflatoksikogene Aspergilli og forbedret anvendelse deraf
ITBS20040045A1 (it)	2004-07-07	Metodo e strumentazione per l'autoapprendimento di una sequenza di operazioni/lavorazioni da effettuarsi su pezzi.
ITRM20020358A1 (it)	2004-01-05	Composizione estetico-farmaceutica per applicazione topica, procedimento per la sua produzione e suoi impieghi.